The Ensign Group, Inc. vs Eli Lilly & Co.
ENSG vs LLY — side-by-side comparison from reported financials. ENSG leads 2, LLY leads 9 of 11 comparable metrics.
The Ensign Group, Inc.
ENSG · Healthcare
$171.80+0.18%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ENSG | LLY |
|---|---|---|
| Price | $171.80 | $1 177.20 |
| Market cap | $10.0B | $1.05T |
| Revenue (TTM) | $5.49B | $79.7B |
| Revenue growth | +18.7% | +31.7% |
| Net margin | 6.9% | 33.5% |
| Free cash flow | $608M | $18.2B |
| Net cash (debt) | ($1.63B) | ($35.2B) |
| 1-year price return | -2.3% | +37.6% |
| P/E | 26.4 | 41.6 |
| P/E vs own history (cheap-side %) | 48% | 88% |
| Dividend yield | 0.15% | 0.52% |
| Return on equity | 17% | 93% |
| Altman Z-score | 3.00 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 46,000 | 50,000 |
Full résumé-style profiles: ENSG CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.